CN Stock MarketDetailed Quotes

600200 JiangSu WuZhong Pharmaceutical Development

Watchlist
  • 10.53
  • +0.27+2.63%
Market Closed Dec 12 15:00 CST
7.50BMarket Cap-198.68P/E (TTM)

JiangSu WuZhong Pharmaceutical Development Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JiangSu WuZhong Pharmaceutical Development Q3 2024 Earnings Date

Currency：CNYOct 22, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
440.80M
--
+9.46%
EPS
--
0.03
--
--
Analyst Rating
Strong Buy

Dec 12, 2024

JiangSu WuZhong Pharmaceutical Development Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.125B--
--2024/FY-- / 2.702B--
--2023/FY2.240B / 2.270B--
--2022/FY2.026B / 1.867B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.125B--
--2024/FY-- / 2.702B--
--2023/FY2.240B / 2.270B--
--2022/FY2.026B / 1.867B--
--------

Unlock Free Earnings Estimates

JiangSu WuZhong Pharmaceutical Development Earnings Reports

  • Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on the main operating data from January to September 2024

    Oct 21 12:00 ET

  • Jiangsu Wu Zhong Medicine Development Co., Ltd. Report for the third quarter of 2024

    Oct 21 12:00 ET

  • Jiangsu Wu Zhong Medicine Development Co., Ltd. 2024 Semi-Annual Report

    Aug 27 12:00 ET

  • Summary of the 2024 semi-annual report of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.

    Aug 27 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Sprint Precision Technologies
    688605
    71.56 +533.84%
    Jiangsu Jingxue Insulation Technology
    301010
    18.10 +20.03%
    Global Infotech
    300465
    18.82 +20.03%
    Hydsoft Technology
    301316
    25.98 +20.00%
    SGSG Science&Technology
    300561
    64.68 +20.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Strong Buy

    • Strong Buy

      50.00%

    • Buy

      50.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Medical Beauty Concept
    Medical Beauty Concept
    Intraday+1.64%
    Assisted Reproduction
    Assisted Reproduction
    Intraday+1.01%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday+1.01%